Corbus Pharmaceuticals Holdings - 12 Year Stock Price History | CRBP

Historical daily share price chart and data for Corbus Pharmaceuticals Holdings since 2014 adjusted for splits and dividends. The latest closing stock price for Corbus Pharmaceuticals Holdings as of January 13, 2026 is 7.94.

The all-time high Corbus Pharmaceuticals Holdings stock closing price was 310.50 on March 20, 2017.
The Corbus Pharmaceuticals Holdings 52-week high stock price is 20.56, which is 158.9% above the current share price.
The Corbus Pharmaceuticals Holdings 52-week low stock price is 4.64, which is 41.6% below the current share price.
The average Corbus Pharmaceuticals Holdings stock price for the last 52 weeks is 9.38.

Corbus Pharmaceuticals Holdings Historical Annual Stock Price Data
Year	Average Stock Price	Year Open	Year High	Year Low	Year Close	Annual % Change
2026	8.0963	7.8700	8.4200	7.8300	7.9400	-2.46%
2025	9.5146	12.0400	19.3600	4.9200	8.1400	-31.02%
2024	33.7405	6.3300	61.5500	5.9300	11.8000	95.36%
2023	6.4121	3.5400	12.0000	2.1400	6.0400	82.20%
2022	8.4232	19.9680	19.9680	3.2400	3.3150	-82.05%
2021	46.6800	38.1000	102.4500	18.1050	18.4710	-50.74%
2020	147.0091	162.0000	281.4000	28.1910	37.5000	-77.11%
2019	188.6798	196.5000	268.5000	128.7000	163.8000	-6.51%
2018	191.5721	238.5000	277.5000	139.5000	175.2000	-17.75%
2017	212.6594	253.5000	310.5000	171.0000	213.0000	-15.98%
2016	119.4940	48.3000	293.7000	31.5000	253.5000	412.12%
2015	73.0601	85.2000	124.5000	45.0000	49.5000	-44.82%

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$0.140B	$0.000B
Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$89.220B	33.89
Zoetis (ZTS)	United States	$55.228B	19.77
Takeda Pharmaceutical (TAK)	Japan	$51.739B	10.56
Daiichi Sankyo, - (DSNKY)	Japan	$43.684B	21.75
BeOne Medicines - (ONC)	Switzerland	$36.626B	194.18
Sandoz Group AG (SDZNY)	Switzerland	$33.097B	0.00
United Therapeutics (UTHR)	United States	$20.770B	18.28
Merck (MKKGY)	Germany	$19.845B	12.23
Shionogi (SGIOY)	Japan	$15.823B	14.53
Neurocrine Biosciences (NBIX)	United States	$13.227B	31.74
Ionis Pharmaceuticals (IONS)	United States	$13.227B	0.00
Summit Therapeutics (SMMT)	United States	$13.140B	0.00
IPSEN (IPSEY)	France	$12.596B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$11.595B	0.00
Orion OYJ (ORINY)	Finland	$11.045B	31.56
Eisai (ESAIY)		$8.889B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.576B	20.00
Grifols, S.A (GRFS)	Spain	$6.284B	0.00
Stevanato Group S.p.A (STVN)	Italy	$6.278B	35.14
Crinetics Pharmaceuticals (CRNX)	United States	$5.252B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.613B	0.00
Indivior (INDV)	United States	$4.321B	17.63
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.080B	19.37
Corcept Therapeutics (CORT)	United States	$3.930B	42.46
NewAmsterdam Pharma (NAMS)	Netherlands	$3.707B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$2.960B	0.00
Hypermarcas (HYPMY)	Brazil	$2.882B	19.78
Catalyst Pharmaceuticals (CPRX)	United States	$2.854B	9.11
Dyne Therapeutics (DYN)	United States	$2.494B	0.00
Ocular Therapeutix (OCUL)	United States	$2.277B	0.00
Soleno Therapeutics (SLNO)	United States	$2.231B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.100B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$2.015B	23.88
Guardian Pharmacy Services (GRDN)	United States	$1.995B	38.43
Ardelyx (ARDX)	United States	$1.788B	0.00
Harrow (HROW)	United States	$1.772B	108.73
Collegium Pharmaceutical (COLL)	United States	$1.522B	7.54
BioCryst Pharmaceuticals (BCRX)	United States	$1.494B	88.62
Oruka Therapeutics (ORKA)	United States	$1.486B	0.00
Enliven Therapeutics (ELVN)	United States	$1.485B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.361B	0.00
Relay Therapeutics (RLAY)	United States	$1.352B	0.00
Evotec AG (EVO)	Germany	$1.335B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.306B	0.00
Savara (SVRA)	United States	$1.174B	0.00
ARS Pharmaceuticals (SPRY)	United States	$1.125B	0.00
Cronos Group (CRON)	Canada	$1.025B	0.00
Xencor (XNCR)	United States	$1.012B	0.00
Theravance Biopharma (TBPH)	United States	$0.996B	41.81
Esperion Therapeutics (ESPR)	United States	$0.849B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.828B	0.00
Nektar Therapeutics (NKTR)	United States	$0.789B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.727B	17.19
Rigel Pharmaceuticals (RIGL)	United States	$0.725B	6.48
ProKidney (PROK)	United States	$0.701B	0.00
Bioventus (BVS)	United States	$0.641B	13.14
Lexeo Therapeutics (LXEO)	United States	$0.593B	0.00
Organogenesis (ORGO)	United States	$0.537B	0.00
Lyell Immunopharma (LYEL)	United States	$0.505B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.497B	0.00
Siga Technologies (SIGA)	United States	$0.472B	6.46
Zevra Therapeutics (ZVRA)	United States	$0.472B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.429B	0.00
Aquestive Therapeutics (AQST)	United States	$0.428B	0.00
Altimmune (ALT)	United States	$0.423B	0.00
Nature's Sunshine Products (NATR)	United States	$0.390B	23.25
USANA Health Sciences (USNA)	United States	$0.377B	10.51
Akebia Therapeutics (AKBA)	United States	$0.372B	0.00
Profound Medical (PROF)	Canada	$0.314B	0.00
Avalo Therapeutics (AVTX)	United States	$0.309B	0.00
Relmada Therapeutics (RLMD)	United States	$0.301B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.301B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.288B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.279B	0.00
OmniAb (OABI)	United States	$0.275B	0.00
Fractyl Health (GUTS)	United States	$0.274B	0.00
Heron Therapeutics (HRTX)	United States	$0.273B	0.00
Protara Therapeutics (TARA)	United States	$0.271B	0.00
Larimar Therapeutics (LRMR)	United States	$0.269B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.248B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.226B	0.00
Journey Medical (DERM)	United States	$0.210B	0.00
Galectin Therapeutics (GALT)	United States	$0.204B	0.00
VAXART, INC (VXRT)	United States	$0.192B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.192B	0.00
MediWound (MDWD)	Israel	$0.191B	0.00
Minerva Neurosciences (NERV)	United States	$0.187B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Century Therapeutics (IPSC)	United States	$0.178B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.161B	0.00
AleAnna (ANNA)	United States	$0.155B	0.00
Surrozen (SRZN)	United States	$0.154B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.150B	0.00
Prelude Therapeutics (PRLD)	United States	$0.138B	0.00
Context Therapeutics (CNTX)	United States	$0.137B	0.00
Incannex Healthcare (IXHL)	Australia	$0.135B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.129B	0.00
Pyxis Oncology (PYXS)	United States	$0.128B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.128B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.126B	0.00
Avita Medical (RCEL)	United States	$0.104B	0.00
Cassava Sciences (SAVA)	United States	$0.102B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.096B	0.00
Vivani Medical (VANI)	United States	$0.093B	0.00
Champions Oncology (CSBR)	United States	$0.093B	39.53
Korro Bio (KRRO)	United States	$0.084B	0.00
Gain Therapeutics (GANX)	United States	$0.082B	0.00
PolyPid (PYPD)	Israel	$0.074B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.071B	59.00
Dominari Holdings (DOMH)	United States	$0.069B	0.00
Plus Therapeutics (PSTV)	United States	$0.068B	0.00
Arch Biopartners (ACHFF)	Canada	$0.067B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.066B	0.00
Metagenomi (MGX)	United States	$0.066B	0.00
Rafael Holdings (RFL)	United States	$0.064B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.062B	0.00
Assertio Holdings (ASRT)	United States	$0.060B	0.00
Lite Strategy (LITS)	United States	$0.053B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.051B	0.00
Nutriband (NTRB)	United States	$0.051B	0.00
ElectroCore (ECOR)	United States	$0.051B	0.00
Lipocine (LPCN)	United States	$0.050B	0.00
Talphera (TLPH)	United States	$0.048B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.046B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Wellgistics Health (WGRX)	United States	$0.039B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.037B	0.00
FibroGen (KYNB)	United States	$0.037B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.036B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.031B	0.00
Natural Alternatives (NAII)	United States	$0.029B	0.00
SCYNEXIS (SCYX)	United States	$0.028B	0.00
Klotho Neurosciences (KLTO)	United States	$0.025B	0.00
TherapeuticsMD (TXMD)	United States	$0.024B	0.00
Scienture Holdings (SCNX)	United States	$0.022B	0.00
Inotiv (NOTV)	United States	$0.021B	0.00
Liminatus Pharma (LIMN)	United States	$0.021B	0.00
Cosmos Health (COSM)	United States	$0.019B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Vivos Therapeutics (VVOS)	United States	$0.019B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.018B	0.00
Vyome Holdings (HIND)	United States	$0.018B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.017B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.017B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
Tempest Therapeutics (TPST)	United States	$0.014B	0.00
CASI Pharmaceuticals (CASI)	China	$0.013B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.013B	0.00
BioLineRx (BLRX)	Israel	$0.012B	0.00
Mangoceuticals (MGRX)	United States	$0.011B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.010B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.010B	0.00
Traws Pharma (TRAW)	United States	$0.010B	0.01
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.010B	0.00
BioVie (BIVI)	United States	$0.010B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
Nuvilex (PMCB)	United States	$0.009B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.008B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.007B	0.00
Heatwurx (PCSA)	United States	$0.007B	0.00
Indaptus Therapeutics (INDP)	United States	$0.007B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.007B	0.00
Aptorum Group (APM)	United Kingdom	$0.007B	0.00
Redhill Biopharma (RDHL)	Israel	$0.006B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.005B	0.00
Salarius Pharmaceuticals (DCOY)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
Lyra Therapeutics (LYRA)	United States	$0.004B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Clearmind Medicine (CMND)	Canada	$0.003B	0.00
Jaguar Animal Health (JAGX)	United States	$0.003B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.002B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00